Kura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call Transcript May 1, 2025
Kura Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $-0.51.
Operator: Good day everyone and welcome to today’s First Quarter 2025 Kura Oncology Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note...
